NVS - Amgen court hearing in patent lawsuit vs Sandoz over generic Prolia cancelled (update)
2024-04-30 11:23:00 ET
More on Amgen
- Amgen: I Prefer To Chase Value And Dividends
- Amgen: The Giant With An Impressive Pipeline
- Move Over Eli Lilly: Amgen Could Be The Next Obesity Wonder Stock
- Amgen’s Blincyto data send Cullinan higher
- AbbVie keeps Humira market share near 100% despite biosimilars: report